GMDA Projected Dividend Yield
Ord/Gamida Cell Ltd ( NASDAQ : GMDA )Gamida Cell is a cell therapy company working to turn cells into therapeutics. Co. applies a proprietary expansion platform utilizing the properties of nicotinamide to allogeneic cell sources including umbilical cord blood-derived cells and natural killer (NK) cells to create cell therapy candidates. Co.'s primary product candidate, omidubicel, is a cell therapy for allogeneic hematopoietic stem cell transplant. Co.'s clinical stage NK cell therapy candidate, GDA-201, is in the Phase 1/2 clinical trial of GDA-201 for the treatment of follicular and diffuse large B-cell lymphomas. 20 YEAR PERFORMANCE RESULTS |
GMDA Dividend History Detail GMDA Dividend News GMDA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |